258 related articles for article (PubMed ID: 25189434)
21. Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.
Brooks B; Delaney-Robinson C; Molyneaux L; Yue DK
J Diabetes Complications; 2008; 22(2):88-95. PubMed ID: 18280438
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of skin vasomotor reflexes in response to deep inspiration in diabetic patients by laser Doppler flowmetry. A new approach to the diagnosis of diabetic peripheral autonomic neuropathy.
Aso Y; Inukai T; Takemura Y
Diabetes Care; 1997 Aug; 20(8):1324-8. PubMed ID: 9250463
[TBL] [Abstract][Full Text] [Related]
23. Effects of a short-term improvement in glycaemic control on skin microvascular dysfunction in Type 1 and Type 2 diabetic patients.
Meyer MF; Rose CJ; Schatz H; Klein HH
Diabet Med; 2009 Sep; 26(9):880-6. PubMed ID: 19719708
[TBL] [Abstract][Full Text] [Related]
24. Skin blood flow response to locally applied mechanical and thermal stresses in the diabetic foot.
Jan YK; Shen S; Foreman RD; Ennis WJ
Microvasc Res; 2013 Sep; 89():40-6. PubMed ID: 23727385
[TBL] [Abstract][Full Text] [Related]
25. Rheological and microvascular parameters in diabetic peripheral neuropathy.
Young MJ; Bennett JL; Liderth SA; Veves A; Boulton AJ; Douglas JT
Clin Sci (Lond); 1996 Mar; 90(3):183-7. PubMed ID: 8777823
[TBL] [Abstract][Full Text] [Related]
26. Impaired skin microvascular reactivity in painful diabetic neuropathy.
Quattrini C; Harris ND; Malik RA; Tesfaye S
Diabetes Care; 2007 Mar; 30(3):655-9. PubMed ID: 17327336
[TBL] [Abstract][Full Text] [Related]
27. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
Casellini CM; Barlow PM; Rice AL; Casey M; Simmons K; Pittenger G; Bastyr EJ; Wolka AM; Vinik AI
Diabetes Care; 2007 Apr; 30(4):896-902. PubMed ID: 17392551
[TBL] [Abstract][Full Text] [Related]
28. Impaired microvascular flow motion in subclinical diabetic feet with sudomotor dysfunction.
Sun PC; Chen CS; Kuo CD; Lin HD; Chan RC; Kao MJ; Wei SH
Microvasc Res; 2012 Mar; 83(2):243-8. PubMed ID: 21722653
[TBL] [Abstract][Full Text] [Related]
29. Degree of adiposity and obesity severity is associated with cutaneous microvascular dysfunction in type 2 diabetes.
Lanting SM; Way KL; Sabag A; Sultana RN; Johnson NA; Baker MK; Gerofi JA; Caterson ID; Twigg SM; Chuter VH
Microvasc Res; 2021 Jul; 136():104149. PubMed ID: 33647342
[TBL] [Abstract][Full Text] [Related]
30. Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross-sectional study.
Walther G; Obert P; Dutheil F; Chapier R; Lesourd B; Naughton G; Courteix D; Vinet A
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):1022-9. PubMed ID: 25657309
[TBL] [Abstract][Full Text] [Related]
31. Post-occlusive reactive hyperaemia of skin microvasculature and foot complications in type 2 diabetes.
Lanting SM; Barwick AL; Twigg SM; Johnson NA; Baker MK; Chiu SK; Caterson ID; Chuter VH
J Diabetes Complications; 2017 Aug; 31(8):1305-1310. PubMed ID: 28545894
[TBL] [Abstract][Full Text] [Related]
32. Differences in skin microcirculation on the upper and lower extremities in patients with diabetes mellitus: relationship of diabetic neuropathy and skin microcirculation.
Tomešová J; Gruberova J; Lacigova S; Cechurova D; Jankovec Z; Rusavy Z
Diabetes Technol Ther; 2013 Nov; 15(11):968-75. PubMed ID: 23964895
[TBL] [Abstract][Full Text] [Related]
33. Non-invasive tests of neurovascular function.
Westerman RA; Widdop RE; Hannaford J; Hogan C; Roberts R; Zimmet P
Clin Exp Neurol; 1987; 24():129-37. PubMed ID: 3268338
[TBL] [Abstract][Full Text] [Related]
34. The association of diabetic microvascular and macrovascular disease with cutaneous circulation in patients with type 2 diabetes mellitus.
Eleftheriadou I; Tentolouris A; Grigoropoulou P; Tsilingiris D; Anastasiou I; Kokkinos A; Perrea D; Katsilambros N; Tentolouris N
J Diabetes Complications; 2019 Feb; 33(2):165-170. PubMed ID: 30446479
[TBL] [Abstract][Full Text] [Related]
35. Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy.
Arora S; Smakowski P; Frykberg RG; Simeone LR; Freeman R; LoGerfo FW; Veves A
Diabetes Care; 1998 Aug; 21(8):1339-44. PubMed ID: 9702444
[TBL] [Abstract][Full Text] [Related]
36. Association Between Arterial Stiffness and Skin Microvascular Function: The SUVIMAX2 Study and The Maastricht Study.
van Sloten TT; Czernichow S; Houben AJ; Protogerou AD; Henry RM; Muris DM; Schram MT; Sep SJ; Dagnelie PC; van der Kallen CJ; Schaper NC; Blacher J; Hercberg S; Levy BI; Stehouwer CD
Am J Hypertens; 2015 Jul; 28(7):868-76. PubMed ID: 25523296
[TBL] [Abstract][Full Text] [Related]
37. Microvascular aspects of diabetic foot disease.
Tooke JE; Brash PD
Diabet Med; 1996; 13 Suppl 1():S26-9. PubMed ID: 8741825
[No Abstract] [Full Text] [Related]
38. Diabetic retinopathy is related to both endothelium-dependent and -independent responses of skin microvascular flow.
Nguyen TT; Shaw JE; Robinson C; Kawasaki R; Wang JJ; Kreis AJ; Wong TY
Diabetes Care; 2011 Jun; 34(6):1389-93. PubMed ID: 21515845
[TBL] [Abstract][Full Text] [Related]
39. Methodological issues in the assessment of skin microvascular endothelial function in humans.
Cracowski JL; Minson CT; Salvat-Melis M; Halliwill JR
Trends Pharmacol Sci; 2006 Sep; 27(9):503-8. PubMed ID: 16876881
[TBL] [Abstract][Full Text] [Related]
40. Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction.
Meyer MF; Lieps D; Schatz H; Pfohl M
Microvasc Res; 2008 May; 76(1):61-5. PubMed ID: 18448131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
